Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases.

Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Abstract Text:

    w t yuhW T Yuh,j d engelkenJ D Engelken,m g muhonenM G Muhonen,n a mayrN A Mayr,d j fisherD J Fisher,j c ehrhardtJ C Ehrhardt,

    PURPOSE: To assess the effectiveness and safety of higher doses of gadoteridol in the MR evaluation of patients with brain metastases. MATERIALS AND METHODS: Thirty-one patients with a clinical suspicion of brain metastases were studied prospectively with gadoteridol, a new, nonionic, low-osmolality contrast agent. Each patient received an initial injection of 0.1 mmol/kg and an additional dose of 0.2 mmol/kg 30 minutes later. Images were obtained before, immediately after, and 10 and 20 minutes after the initial dose. Images also were acquired immediately after the additional dose of gadoteridol. RESULTS: No adverse effects were attributed to the injection of gadoteridol. Four patients' examinations were excluded from analysis because of machine malfunction (two patients) and excessive motion artifact (two patients). Four patients had no detectable metastases. After the additional dose of gadoteridol, there was a marked qualitative improvement in lesion conspicuity and detection. The conspicuity of 80 of 81 lesions was increased in the high-dose studies, and 46 new lesions were detected in 19 of 27 patients. Quantitative image analysis demonstrated a significant increase in normalized mean lesion contrast between the initial-dose and high-dose studies (35 lesions identified in 13 patients, P less than .0001). The additional information gained by high-dose examinations contributed to a potential modification of the treatment in 10 of 27 patients. High-dose examinations increased flow-related artifact in the posterior fossa in 12 of 27 patients. CONCLUSION: Based on our preliminary results, high-dose gadolinium-enhanced MR examinations may have advantages over 0.1 mmol/kg examinations in detecting early and/or small metastases. This may be significant in the management of patients with cerebral metastases.

    Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Publishing Authors By Initials

    wt yuhWT Yuh,jd engelkenJD Engelken,mg muhonenMG Muhonen,na mayrNA Mayr,dj fisherDJ Fisher,jc ehrhardtJC Ehrhardt,

    For similar investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: epidemiologic studies: cohort studies: longitudinal studies: prospective studies research abstracts see: investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: epidemiologic studies: cohort studies: longitudinal studies: prospective studies research

    PUBMED ID PMID:

    MEDLINE DATE:

    Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: AJNR. American journal of neuroradiology

    VOLUME: 13

    Page Numbers: 335-45

    Journal Abbreviation:

    ISSN: 0195-6108

    DAY: 14

    MONTH: 02

    YEAR: 2008

    Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8003708

    Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Keywords Mesh Terms:

    KEYWORDS: Prospective Studies

    MESH TERMS: diagnostic use

    Chemical & Substance for Abstract: Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. Information

    Substance Name: Gadolinium

    Registry Number: 7440-54-2

    Grant and Affiliation Information for Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases.

    AFFILIATION: Department of Radiology, University of Iowa College of Medicine, Iowa City, IA 52242.

    Country: UNITED STATES

    UNITED STATES Research PublicationUNITED STATES Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: AJNR Am J Neuroradiol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News